WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform

the human performance company, today announced it has raised $575 million in Series G funding at a $10.1 billion valuation, advancing its global expansion and long-term vision for personalized health. The round was led by Collaborative Fund and includes global participation from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital (entities administered by Macquarie Capital), Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures, and Bullhound Capital alongside a group of prominent global athletes and individual investors.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331399622/en/

 

 

 

Individual investors in the round include Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Karen Wazen, Virgil van Dijk, Mathieu van der Poel, and Shane Lowry, underscoring the deep connection between WHOOP and elite performance, health, and global culture.

 

This funding comes at a defining moment for WHOOP and the future of health. Chronic disease is rising globally, while many healthcare systems remain built for reactive care. At the same time, advances in AI and continuous biometric data are enabling a fundamentally new approach that predicts risk, guides behavior, and improves health in real time. WHOOP has spent over a decade building toward this moment. With this investment, the company will accelerate global expansion and scale its platform as a new standard for personalized, preventive health.

 

 

“Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan,” said Will Ahmed, Founder and CEO of WHOOP. “We are building the personal health platform that people use to improve their health and livelihood.”

 

 

Accelerating International Growth

 

 

WHOOP is experiencing rapid global momentum amid an extraordinary period of growth:

 

 

• The company now has over 2.5 million members around the world
• In 2025, bookings grew 103% year-over-year, exiting the year at a $1.1B run rate
• In 2025, WHOOP operated cash flow positive
• WHOOP is hiring for over 600 new roles around the world this year to support research and development and international expansion

 

Proceeds from this Series G financing will fuel further U.S. growth and international expansion across Europe, the GCC, Latin America, and Asia.

 

Building the Preeminent Global Health Platform

 

 

This financing will accelerate WHOOP in building the world’s leading personal health platform – an intelligent, unified system designed to extend healthspan, optimize performance, and prevent disease before it begins.

 

 

Abbott, a global healthcare leader, joins as a strategic investor. With a broad portfolio spanning diagnostics, medical devices, nutrition, and generic medicines, Abbott brings deep healthcare expertise, scale, and a track record of health tech innovation, creating solutions that are more responsive, connected, and personalized. WHOOP and Abbott share a commitment to empowering people to take control of their health.

 

 

Powered by more than 24 billion hours of physiological data and purpose-built AI models, WHOOP delivers predictive, personalized health insights. Members open the app an average of over eight times per day – almost three times higher than other screenless wearables – to understand how they slept, whether they are recovered, how hard to push or pull back, and how daily behaviors like training, nutrition, and stress are impacting their performance and long-term health. These insights go beyond sleep and fitness, helping members identify early warning signs, reduce risk, and take action that can prevent serious health events. From world leaders and executives to elite athletes and artists, WHOOP has become an essential platform for those committed to performing and living at their highest level.

 

 

“WHOOP has become one of the most important tools I use to support my long-term health,” said Cristiano Ronaldo, a WHOOP investor and global ambassador. “I am proud to participate in this round because I believe in the future we are building together. No other company has created a health platform this powerful that people are proud to wear.”

 

 

To learn more about the company’s vision for the future of health, click here. Press materials, including imagery, are available here.

 

 

About WHOOP

 

 

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.

 

 

Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $900 million in venture capital, ships to 56 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260331399622/en/

 

boerse | 69038405 |